Drug Substance Salt Selection Case Study
CASE STUDY: Drug Substance Salt Selection
To manufacture drug substance and screen a selection of corresponding pharmaceutically acceptable salt forms. From the resulting salt forms, choose a candidate which exhibits optimal characteristics for formulation and bioavailability.
API was manufactured at ARCINOVA and a series of salts subsequently produced. Each salt form was assessed with respect to salt formation, solubility, hygroscopicity, crystallinity, polymorph tendency, chemical stability and particle size/morphology. An optimal salt form was identified and manufactured at ARCINOVA.
Nordic Life Science DaysNordic Life Science Days annual conference will be attended by Nathalie Huther, Business Development Manager Europe.
Nordic Life Science DaysDates: 10th - 12th SeptemberLocation: Stockholm, Sweden
Chem OutsourcingChem Outsourcing will be attended by Paul Quigley, Head of API Development.
Chem OutsourcingDates: 17th - 19th SeptemberLocation: Long Branch, NJ
Bio SpainBioSpain 2018 will be attended by Nathalie Huther, Business Development Manager Europe.
Bio SpainDates: 25th - 27th SeptemberLocation: Seville, Spain